Balyasny Asset Management LLC Uni Qure N.V. Transaction History

Balyasny Asset Management LLC

$63.6 Billion
Q4 2024

A detailed history of Balyasny Asset Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 359,173 shares of QURE stock, worth $5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

359,173

Previous 233,491 53.83%

Holding current value

$5 Million

Previous $1.15 Million 451.0%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.54 - $17.73 $570,596 - $2.23 Million	125,682 Added 53.83%	359,173 $6.34 Million
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $708,077 - $1.9 Million	187,322 Added 405.73%	233,491 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $76,293 - $94,367	17,379 Added 60.36%	46,169 $206,000
Q1 2024 May 13, 2024	BUY	$4.82 - $6.93 $47,091 - $67,706	9,770 Added 51.37%	28,790 $149,000
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $107,082 - $157,295	19,020 New	19,020 $128,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $3 Million - $5.98 Million	269,449 Added 80.18%	605,515 $6.94 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $6.28 Million - $7.75 Million	336,066 New	336,066 $6.77 Million
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $6.16 Million - $9.59 Million	468,753 Added 191.73%	713,240 $13.3 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $3.24 Million - $4.79 Million	222,942 Added 1034.77%	244,487 $4.42 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $436,070 - $775,835	21,545 New	21,545 $447,000
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $3.69 Million - $5.3 Million	-104,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $3.76 Million - $4.98 Million	104,500 New	104,500 $3.85 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $709,469 - $1.07 Million	-15,745 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $3.22 Million - $5.95 Million	-80,491 Reduced 83.64%	15,745 $747,000
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $2.75 Million - $5.52 Million	73,994 Added 332.68%	96,236 $6.9 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $179,206 - $349,670	-4,553 Reduced 16.99%	22,242 $875,000
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $985,134 - $1.53 Million	18,672 Added 229.87%	26,795 $2.09 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $222,488 - $555,694	8,123 New	8,123 $485,000
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $3.61 Million - $5.38 Million	-158,471 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $1.5 Million - $2.17 Million	50,471 Added 46.73%	158,471 $5.77 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $2.37 Million - $4.31 Million	108,000 New	108,000 $4.08 Million

Others Institutions Holding QURE

# of Institutions

171

Shares Held

42.5M

Call Options Held

2.61M

Put Options Held

582K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $651M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Uni Qure N.V. Transaction History